This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma
BMC Ophthalmology Open Access 10 August 2023
-
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
British Journal of Cancer Open Access 15 July 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Nathan, P. et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N. Engl. J. Med. 385, 1196–1206 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Tebentafusp for uveal melanoma. Nat Rev Clin Oncol 18, 747 (2021). https://doi.org/10.1038/s41571-021-00572-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00572-3
This article is cited by
-
Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma
BMC Ophthalmology (2023)
-
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
British Journal of Cancer (2023)